@BianchiniGP
Giampaolo Bianchini
2 years
📢Glass ceiling are meant to be broken for paradigm-shift advancement DB04 did it👏👏 HER2 “addiction” is not mandatory anymore for targeting successfully target HER2❗️ HER2low is only a pragmatic (and imperfect) way for patient selection (DAISY trial) ⁦ @ASCO #BCSM
Tweet media one
1
14
76

Replies

@antgiorda
Antonio Giordano, MD PhD
2 years
1
0
3
@BianchiniGP
Giampaolo Bianchini
2 years
@antgiorda @ASCO 😛… These results are “poesia” The standing ovation confirmed that my feelings were shared by most
0
0
1